Sky Investment Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.3M Buy
40,786
+415
+1% +$89.3K 1.61% 17
2026
Q1
$8.78M Sell
40,371
-627
-2% -$139K 1.51% 22
2025
Q4
$9.37M Buy
40,998
+393
+1% +$89.5K 1.55% 19
2025
Q3
$9.4M Sell
40,605
-2,219
-5% -$452K 1.58% 16
2025
Q2
$7.95M Sell
42,824
-20
-0% -$3.72K 1.39% 22
2025
Q1
$8.98M Buy
42,844
+129
+0.3% +$25.1K 1.66% 19
2024
Q4
$7.59M Buy
42,715
+3,936
+10% +$724K 1.39% 27
2024
Q3
$7.66M Sell
38,779
-205
-0.5% -$38.3K 1.38% 27
2024
Q2
$6.69M Buy
38,984
+348
+0.9% +$57.6K 1.28% 28
2024
Q1
$7.04M Sell
38,636
-350
-0.9% -$60.3K 1.35% 26
2023
Q4
$6.04M Buy
38,986
+447
+1% +$65.2K 1.27% 31
2023
Q3
$5.74M Sell
38,539
-60
-0.2% -$8.81K 1.3% 31
2023
Q2
$5.2M Buy
38,599
+1,884
+5% +$276K 1.13% 34
2023
Q1
$5.85M Sell
36,715
-120
-0.3% -$18.3K 1.34% 31
2022
Q4
$5.95M Buy
36,835
+2,746
+8% +$421K 1.41% 28
2022
Q3
$4.58M Buy
34,089
+375
+1% +$53.8K 1.19% 35
2022
Q2
$5.16M Buy
33,714
+1,476
+5% +$226K 1.24% 34
2022
Q1
$5.23M Sell
32,238
-225
-0.7% -$32.7K 1.1% 39
2021
Q4
$4.39M Buy
32,463
+725
+2% +$85.6K 0.89% 42
2021
Q3
$3.42M Buy
31,738
+393
+1% +$44.9K 0.76% 50
2021
Q2
$3.53M Sell
31,345
-405
-1% -$45.6K 0.8% 50
2021
Q1
$3.44M Sell
31,750
-4,357
-12% -$466K 0.82% 48
2020
Q4
$3.87M Sell
36,107
-5,132
-12% -$493K 0.98% 40
2020
Q3
$3.61M Buy
41,239
+24,960
+153% +$2.35M 0.99% 39
2020
Q2
$1.6M Buy
16,279
+925
+6% +$81.4K 0.55% 58
2020
Q1
$1.17M Buy
15,354
+455
+3% +$38.8K 0.47% 59
2019
Q4
$1.32M Buy
14,899
+485
+3% +$40.3K 0.43% 58
2019
Q3
$1.09M Buy
14,414
+4,995
+53% +$342K 0.38% 61
2019
Q2
$685K Sell
9,419
-795
-8% -$62.5K 0.24% 70
2019
Q1
$823K Sell
10,214
-450
-4% -$36.8K 0.3% 67
2018
Q4
$983K Sell
10,664
-425
-4% -$37.4K 0.41% 56
2018
Q3
$1.05M Sell
11,089
-220
-2% -$20.9K 0.4% 60
2018
Q2
$1.05M Sell
11,309
-466
-4% -$45.5K 0.42% 59
2018
Q1
$1.11M Sell
11,775
-20
-0.2% -$2.2K 0.45% 58
2017
Q4
$1.14M Sell
11,795
-710
-6% -$66.9K 0.45% 59
2017
Q3
$1.11M Hold
12,505
0.46% 60
2017
Q2
$907K Sell
12,505
-240
-2% -$16.1K 0.38% 63
2017
Q1
$830K Sell
12,745
-660
-5% -$41.5K 0.37% 62
2016
Q4
$839K Sell
13,405
-515
-4% -$31.4K 0.39% 61
2016
Q3
$878K Sell
13,920
-110
-0.8% -$7.12K 0.41% 59
2016
Q2
$869K Sell
14,030
-263
-2% -$16K 0.41% 58
2016
Q1
$816K Sell
14,293
-70
-0.5% -$3.9K 0.4% 57
2015
Q4
$851K Sell
14,363
-50
-0.3% -$2.88K 0.44% 58
2015
Q3
$784K Sell
14,413
-25
-0.2% -$1.63K 0.44% 57
2015
Q2
$970K Sell
14,438
-275
-2% -$18K 0.51% 55
2015
Q1
$861K Sell
14,713
-953
-6% -$57.6K 0.46% 56
2014
Q4
$1.02M Sell
15,666
-540
-3% -$34K 0.53% 55
2014
Q3
$936K Buy
16,206
+2,765
+21% +$154K 0.51% 55
2014
Q2
$759K Sell
13,441
-4,743
-26% -$249K 0.45% 56
2014
Q1
$935K Sell
18,184
-2,777
-13% -$140K 0.52% 56
2013
Q4
$1.11M Buy
20,961
+15,921
+316% +$782K 0.63% 52
2013
Q3
$225K Buy
+5,040
New +$223K 0.58% 52

Other funds holding ABBV

Sky Investment Group's ABBV Position: Q2 2026 in Review

Sky Investment Group increased its AbbVie (ABBV) stake by 1% in Q2 2026, buying an estimated $89.3K and bringing the position to 40,786 shares worth $10.3M. The position accounts for 1.61% of the portfolio, ranked #17.

Sky Investment Group first reported a position in ABBV in Q3 2013 and has held it in 52 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sky Investment Group held 40,786 shares of AbbVie worth $10.3M as of Q2 2026.
  • Sky Investment Group bought 415 AbbVie shares in Q2 2026, an estimated $89.3K.
  • AbbVie made up 1.61% of Sky Investment Group's portfolio in Q2 2026, its #17 holding.
  • Sky Investment Group first reported a position in AbbVie in Q3 2013 and has held it in 52 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sky Investment Group's 13F filing for Q2 2026, filed 20 Jul 2026.